Diagnostics drives revenue growth at Rutherford

Cancer treatment specialist Rutherford Health has booked a 36% jump in revenue in H1 despite a reduction in the number of cancer patients due to the Covid-19 pandemic. CEO Mike Moran said growth had been driven by expansion of the Group’s diagnostic services. Revenue for the six months ended 31 August 2021 came in at £4.9m…

You must be a HM Subscriber to view this content.

Subscribe Now »